Added to YB: 2025-01-31
Pitch date: 2025-01-29
ZTS [bullish]
Zoetis Inc.
-24.77%
current return
Author Info
Devil Investors talk about the stock market and analyze companies that they like. Sign up for the newsletter.
Company Info
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
Market Cap
$53.0B
Pitch Price
$169.18
Price Target
250.00 (+96%)
Dividend
1.69%
EV/EBITDA
14.37
P/E
20.86
EV/Sales
6.34
Sector
Pharmaceuticals
Category
growth
Zoetis Inc. - $ZTS
ZTS: Leader in animal health, 70% gross margin, 38% op margin. $9B rev, 6% CAGR. Strong R&D, 15 blockbusters. Librela/Solensia growing 97% YoY. EU antitrust risk. 10% FCF growth. Trading near historic low multiples. $250 PT by 2029. Buy below $160.
Read full article (19 min)